Solaria Bio
1 known investors
Solaria develops plant-sourced living synbiotics (probiotic-prebiotic products) marketed as medical foods for inflammatory conditions, starting with Bōndia for bone loss in women with osteopenia and a forthcoming product, Arthrīva, for rheumatoid arthritis. The company builds a library of plant-based microbiome solutions backed by clinical trials and a Harvard Medical School partnership.
Investors · 1
Frequently asked questions
- What does Solaria Bio do?
- Solaria develops plant-sourced living synbiotics (probiotic-prebiotic products) marketed as medical foods for inflammatory conditions, starting with Bōndia for bone loss in women with osteopenia and a forthcoming product, Arthrīva, for rheumatoid arthritis. The company builds a library of plant-based microbiome solutions backed by clinical trials and a Harvard Medical School partnership.
- Who are Solaria Bio's investors?
- Solaria Bio's investors include Bold Capital Partners.